Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.

Abstract excerpt

Current smoking cessation treatments are not optimal as the long-term abstinence rates are low. Nicotine replacement therapy and bupropion are the only pharmacotherapies widely available to smokers and there is a need to improve current cessation treatments and to develop new drug therapies. Our goal is to use pharmacogenetic information to improve smoking cessation treatments. Candidate genes include those...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aryl Hydrocarbon Hydroxylases
• Share to Cytochrome P-450 CYP2A6